These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27031904)

  • 1. Discrepancy between immunosuppressive status and extensiveness of fungal infections?
    dos Santos VM; dos Santos LA
    Infez Med; 2016; 24(1):87-8. PubMed ID: 27031904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amphotericin B: the end of an era].
    Rommes JH; Spronk PE; Saene HK
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):106; author reply 106-7. PubMed ID: 15688845
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
    Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
    Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B.
    Fay VDS; Rodrigues DMG; Gonçalves SMB; Gregianini TS; Bonamigo RR
    An Bras Dermatol; 2018 Jun; 93(3):462-464. PubMed ID: 29924220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1990 Jun; 32(820):58-60. PubMed ID: 2348801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current problems in etiotropic therapy of mycoses].
    Buslaeva GN
    Antibiot Khimioter; 2001; 46(1):35-9. PubMed ID: 11221084
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
    Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
    Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of invasive fungal infections.
    Warnock DW
    Hosp Med; 1998 Apr; 59(4):266-7. PubMed ID: 9722362
    [No Abstract]   [Full Text] [Related]  

  • 10. [New aspects in treatment of systemic mycoses].
    Presterl E; Graninger W
    Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
    Malik IA; Moid I; Aziz Z; Khan S; Suleman M
    Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief review of antifungal therapy for deep fungal infection.
    Muller RJ
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the treatment of severe refractory infections. 4) Deep fungal infection].
    Watanabe K
    Nihon Naika Gakkai Zasshi; 1998 Nov; 87(11):2257-62. PubMed ID: 9921211
    [No Abstract]   [Full Text] [Related]  

  • 14. A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.
    Winston DJ; Hathorn JW; Schuster MG; Schiller GJ; Territo MC
    Am J Med; 2000 Mar; 108(4):282-9. PubMed ID: 11014720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of invasive fungal infections in immunocompromised patients with fluconazole.
    Esposito R; Uberti Foppa C; Cernuschi M
    J Chemother; 1989 Jul; 1(4 Suppl):925-6. PubMed ID: 16312707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of invasive fungal diseases in children].
    Lu Q; Zhao DY
    Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):241-5. PubMed ID: 23927794
    [No Abstract]   [Full Text] [Related]  

  • 17. Amphotericin B vs fluconazole for controlling fungal infections in neutropenic cancer patients.
    Johansen HK; Gotzsche PC
    Cochrane Database Syst Rev; 2000; (3):CD000239. PubMed ID: 10908468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents.
    Yamamoto K; Makimura K; Sudo T; Shibuya K; Uchida K; Yamaguchi H
    J Med Vet Mycol; 1997; 35(6):411-8. PubMed ID: 9467108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emergent mycoses].
    Naito Y
    Nihon Jibiinkoka Gakkai Kaiho; 2004 Jul; 107(7):702-5. PubMed ID: 15386901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.